[ad_1]
LYNCHBURG, Va. (WSET) – The US Food and Drug Administration has alerted health care professionals and patients who are taking drugs for hypertension and heart failure about a new booster.
The recall involves drugs that contain the ingredient Valsartan
Valsartan is used to treat high blood pressure and heart failure, according to the FDA.
He wrote that an impurity was found in valsartan called N-nitrosodimethylamine (NDMA).
"We have carefully evaluated drugs containing valsartan sold in the United States, and we have found that the valsartan sold by these specific companies does not meet our safety standards.That's why we asked for these companies take immediate action to protect patients, "said Janet Woodbad, MD, director of the FDA's Center for Drug Evaluation and Research
on laboratory tests.
retail pharmacies in possession of all unused products, including Valsartan tablets, 40 mg, 80 mg, 160 mg and 320 mg, and Valsartan-HCTZ tablets, 80 mg / 12.5 mg, 160 mg / 12.5 mg, 160 mg / 25 mg, 320 mg / 12.5 mg and 320 mg / 25 mg, between the due dates of July 2018 to January 2020, must immediately return the product
[19659002] FDA believes that the sudden presence of NDMA is due to the way the substance was manufactured.
Some of the drug recall companies include Major Pharmeceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd.
Source link
